Brief: Knight Therapeutics To Acquire Regional Rights To Exelon
April 23 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT THERAPEUTICS TO ACQUIRE REGIONAL RIGHTS TO EXELON®
* KNIGHT THERAPEUTICS TO ACQUIRE REGIONAL RIGHTS TO EXELON®
* KNIGHT THERAPEUTICS - AT CLOSING, WILL PAY USD $168
MILLION IN
CASH & ADDITIONAL MILESTONE PAYMENT OF UP TO USD $12 MILLION
UPON ACHIEVEMENT OF SOME CONDITIONS
* KNIGHT THERAPEUTICS - WILL BEGIN DISTRIBUTING EXELON UPON
TRANSFER OF MARKETING AUTHORIZATION, ON A COUNTRY BY COUNTRY
BASIS
Source text for Eikon: ID:nGNXYCwW8
Further company coverage: GUD.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Knight Therapeutics
See all newsBrief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil
Brief: Knight Therapeutics - Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia
Brief: Knight Therapeutics Enters Into Exclusive Distribution Agreement With Kyowa Kirin International For Poteligeo® (Mogamulizumab)
Brief: Knight Therapeutics Announces Regulatory Approval Of Tavalisse® In Colombia
Brief: Knight Therapeutics Announces Supplemental Regulatory Submission For Minjuvi In Brazil